Skip to main content
main-content

Zeitschrift

Cancer Chemotherapy and Pharmacology

Cancer Chemotherapy and Pharmacology 1/2019

Ausgabe 1/2019

Inhaltsverzeichnis ( 24 Artikel )

06.04.2019 | Review Article | Ausgabe 1/2019

Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain

Sara Emad El-Agamy, Amal Kamal Abdel-Aziz, Ahmed Esmat, Samar S. Azab

11.05.2019 | Review Article | Ausgabe 1/2019

Uveal melanoma: physiopathology and new in situ-specific therapies

E. B. Souto, A. Zielinska, M. Luis, C. Carbone, C. Martins-Gomes, S. B. Souto, A. M. Silva

13.04.2019 | Original Article | Ausgabe 1/2019

Platinum-free interval affects efficacy of following treatment for platinum-refractory or -resistant ovarian cancer

Mayumi Kobayashi-Kato, Mayu Yunokawa, Seiko Bun, Naoyuki Miyasaka, Tomoyasu Kato, Kenji Tamura

20.04.2019 | Original Article | Ausgabe 1/2019 Open Access

Sunitinib in pediatric patients with advanced gastrointestinal stromal tumor: results from a phase I/II trial

Arnauld C. Verschuur, Viera Bajčiová, Leo Mascarenhas, Reza Khosravan, Xun Lin, Antonella Ingrosso, Katherine A. Janeway

24.04.2019 | Original Article | Ausgabe 1/2019 Open Access

Resistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics

Hitesh B. Mistry, Gabriel Helmlinger, Nidal Al-Huniti, Karthick Vishwanathan, James Yates

29.04.2019 | Original Article | Ausgabe 1/2019

Monomethyl auristatin E-conjugated anti-EGFR antibody inhibits the growth of human EGFR-positive non-small cell lung cancer

Zhuanglin Li, Mingxue Wang, Deling Yu, Wenting Luo, Jianmin Fang, Changjiang Huang, Xuejing Yao

30.04.2019 | Original Article | Ausgabe 1/2019

Pharmacokinetics and safety of lobaplatin plus etoposide in Chinese men older than 65 years with extensive-stage small cell lung cancer: a phase II clinical trial

Jianhua Chen, Bingyang Liu, Fang Zhang, Weiping Cui, Peng Zhang

03.05.2019 | Original Article | Ausgabe 1/2019 Open Access

Population pharmacokinetics of PF-05280014 (a trastuzumab biosimilar) and reference trastuzumab (Herceptin®) in patients with HER2-positive metastatic breast cancer

Xiaoying Chen, Cheryl Li, Reginald Ewesuedo, Donghua Yin

06.05.2019 | Original Article | Ausgabe 1/2019

A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [14C]-labeled idasanutlin and an intravenous tracer dose of [13C]-labeled idasanutlin in a single cohort of patients with solid tumors

Zsuzsanna Pápai, Lin-Chi Chen, Daniel Da Costa, Steven Blotner, Faye Vazvaei, Michelle Gleave, Russell Jones, Jianguo Zhi

08.05.2019 | Original Article | Ausgabe 1/2019

Orally administered salecan ameliorates methotrexate-induced intestinal mucositis in mice

Yan Gao, Qi Sun, Xiao Yang, Weiling Lu, Yang Zhao, Wenhao Ge, Yunxia Yang, Xi Xu, Jianfa Zhang

11.05.2019 | Original Article | Ausgabe 1/2019

Treatment with selenium-enriched Saccharomyces cerevisiae UFMG A-905 partially ameliorates mucositis induced by 5-fluorouracil in mice

Bárbara A. A. Porto, Cinthia F. Monteiro, Éricka L. S. Souza, Paola C. L. Leocádio, Jacqueline I. Alvarez-Leite, Simone V. Generoso, Valbert N. Cardoso, Camila M. Almeida-Leite, Daniel A. Santos, Julliana R. A. Santos, Jacques R. Nicoli, Enrica Pessione, Flaviano S. Martins

13.05.2019 | Original Article | Ausgabe 1/2019

Clinical characteristics, treatment patterns and outcomes of patients older than 80 years diagnosed with DLBCL in China over a 10-year period

Zhan Shi, Xi Tang, Qianwen Shen, Jiayan Chen, Fei Liu, Xi Chen, Jingwen Wang, Jie Zhuang

13.05.2019 | Original Article | Ausgabe 1/2019

Inter- and intra-patient variability in pharmacokinetics of abiraterone acetate in metastatic prostate cancer

Malmaruha Arasaratnam, Megan Crumbaker, Atul Bhatnagar, Matthew J. McKay, Mark P. Molloy, Howard Gurney

13.05.2019 | Original Article | Ausgabe 1/2019

Olanzapine-containing antiemetic therapy for the prevention of carboplatin-induced nausea and vomiting

Kazuki Tanaka, Naoki Inui, Masato Karayama, Hideki Yasui, Hironao Hozumi, Yuzo Suzuki, Kazuki Furuhashi, Tomoyuki Fujisawa, Noriyuki Enomoto, Yutaro Nakamura, Hideki Kusagaya, Shun Matsuura, Tomohiro Uto, Dai Hashimoto, Takashi Matsui, Kazuhiro Asada, Takafumi Suda

13.05.2019 | Original Article | Ausgabe 1/2019

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin as a first-line concurrent chemotherapy regimen in nasopharyngeal carcinoma: a prospective, multi-institution, randomized controlled phase II study

Xiang-Yun Kong, Jian-Xun Lu, Xin-Wen Yu, Jian Zhang, Qian-Lan Xu, Rong-Jun Zhang, Jing-Lin Mi, Shu-Fang Liao, Jin-Fang Fan, Xiao-Li Qin, Da-Cheng Yao, Hua-Ying Tang, Wei Jiang

16.05.2019 | Original Article | Ausgabe 1/2019 Open Access

A phase 2 study to assess the pharmacokinetics and pharmacodynamics of CPX-351 and its effects on cardiac repolarization in patients with acute leukemias

Tara L. Lin, Laura F. Newell, Robert K. Stuart, Laura C. Michaelis, Eric Rubenstein, Helen S. Pentikis, Timothy Callahan, Donna Alvarez, Barry D. Liboiron, Lawrence D. Mayer, Qi Wang, Kamalika Banerjee, Arthur C. Louie

17.05.2019 | Original Article | Ausgabe 1/2019

Pharmacokinetics of trastuzumab emtansine (T-DM1) as a single agent or in combination with pertuzumab in HER2-positive breast cancer patients with recurrent or locally advanced metastatic breast cancer

Dan Lu, Chunze Li, Matthew Riggs, Daniel Polhamus, Jonathan French, Priya Agarwal, Shang-Chiung Chen, Shweta Vadhavkar, Monika Patre, Alexander Strasak, Angelica Quartino, Jin Yan Jin, Sandhya Girish

21.05.2019 | Original Article | Ausgabe 1/2019

Long non-coding RNA GHET1 contributes to chemotherapeutic resistance to Gemcitabine in bladder cancer

Bo Li, Dalon Xie, Hui Zhang

23.05.2019 | Original Article | Ausgabe 1/2019

Renin–angiotensin system inhibitors for countering proteinuria induced by angiogenesis inhibitors: a retrospective observational analysis

Toshinori Hirai, Yukari Shuji, Megumi Takiyama, Kazuhiko Hanada, Toshimasa Itoh

24.05.2019 | Original Article | Ausgabe 1/2019

Clinical implications of an analysis of pharmacokinetics of crizotinib coadministered with dexamethasone in patients with non-small cell lung cancer

Swan Lin, Dana J. Nickens, Maulik Patel, Keith D. Wilner, Weiwei Tan

22.04.2019 | Short Communication | Ausgabe 1/2019

Qualitative and quantitative variations in liver function thresholds among clinical trials in cancer: a need for harmonization

Edwin Wang, Fei Song, Jessica K. Paulus, Douglas Hackenyos, Paul Mathew

30.04.2019 | Short Communication | Ausgabe 1/2019

Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand–foot syndrome: a newly recognized toxicity

Daniel F. Pease, Bruce A. Peterson, Scott Gilles, Maria K. Hordinsky, Kimberly A. Bohjanen, Keith M. Skubitz

12.04.2019 | Letter to the Editor | Ausgabe 1/2019

Efficacy of immunotherapy, gut microbiota and impact of antibiotic use: are there confounding factors?

G. Milano

30.04.2019 | Letter to the Editor | Ausgabe 1/2019

Stress resilience and survival among cancer patients: is there any absolute truth?

Raffaella Mormile

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise